NCT04039672View on ClinicalTrials.gov

Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

July 2, 2024

Study Completion Date

July 2, 2024

Conditions
Melanoma
Interventions
PROCEDURE

Skin biopsy

5mm skin metastasis or primary melanoma biopsy

Trial Locations (1)

69495

Service de Dermatologie, Centre hospitalier Lyon Sud, HCL, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04039672 - Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma | Biotech Hunter | Biotech Hunter